Firstly is was a different psych (MDMA) on a different condition. Secondly the issue was not the results but the way it was run and changing conditions to meet a favourable outcome. Very, very different.
We have great results thus far and like always the good trials and drugs will always succeed if the outcome and safety is beneficial. That landscape is changing every day. By the time our Phase 3 is done it will look very different I would suggest.
It does also highlight how important it is to have so many programs in our war chest.
- Forums
- ASX - By Stock
- IHL
- Clarion clinics
Clarion clinics, page-48
-
-
- There are more pages in this discussion • 12 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add IHL (ASX) to my watchlist
Currently unlisted public company.
The Watchlist
LU7
LITHIUM UNIVERSE LIMITED
Alex Hanly, CEO
Alex Hanly
CEO
SPONSORED BY The Market Online